1. Popovsky MA, Robillard P, Schipperus M, Stainsby D, Tissot JD, Wiersum J. ISBT Working Party on Haemovigilance. Proposed standard definitions for surveillance of noninfectious adverse transfusion reactions. 2011.
2. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108(3):759–69.
3. What is the prevalence of transfusion reactions in the US? [Internet]. [cited 2021 Jan 6]. Available from: https://www.medscape.com/answers/206885-108609/what-is-the-prevalence-of-transfusion-reactions-in-the-us.
4. 2016 Global Status Report on Blood Safety and Availability [Internet]. 2017 [cited 2021 Jan 6]. Available from: https://apps.who.int/iris/bitstream/handle/10665/254987/9789241565431.
5. Haemovigilance Programme of India. National Institute of Biologicals & Indian Pharmacopoeia Commission Collaboration[Internet]. [cited 2021 Jan 6]. Available from: http://nib.gov.in/haemovigilance.html.